Table 1. Participant characteristics of the 39 participants that completed the study protocol. Data were obtained at baseline and values are expressed as mean (± SEM).
|
Total (n=39) |
Citrus Flavonoid (CF) (n=19) |
Placebo (n=20) |
| Age (yr) |
23.0 (.3) |
22.7 (.4) |
23.6 (.4) |
| Weight (kg) |
74.4 (1.29) |
74.1 (1.75) |
74.8 (1.93) |
| Height (m) |
1.84 (.01) |
1.83 (.02) |
1.84 (.02) |
| BMI (kg·m-2) |
22.1 (.30) |
22.1 (.42) |
22.0 (.44) |
| Exercise time per week |
9.6 (.6) |
8.8 (.6) |
10.3 (.9) |
| Absolute power (W) |
299.3 (7.7) |
298.0 (10.8) |
300.5 (11.4) |
| Relative power (W·kg-1) |
4.0 (.1) |
4.0 (.2) |
4.0 (.2) |
| Heart rate (BPM) |
174(2) |
171(4) |
177(3) |
| Average VO2 (mL·kg-1·min) |
50.3 (1.3) |
51.1 (1.6) |
49.6 (2.1) |
| Estimated VO2max (mL·kg-1·min) |
57.1 (1.2) |
57.9 (1.6) |
56.5 (1.8) |
| VO2/Power ratio |
.172 (.003) |
.176 (.005) |
.170 (.004) |
| Peak power output (W) |
332.5 (21.0) |
359.4 (36.0) |
306.8 (22.0) |
No significant differences were found between CF and placebo group at baseline, p > 0.05.
